Clinical Application of Sensimed Triggerfish Sensor (TS) With Wireless Signal Transmission for Continuous Intraocular Pressure Measurement
This study is enrolling participants by invitation only.
Sponsor:
University of Zurich
Information provided by (Responsible Party):
University of Zurich
ClinicalTrials.gov Identifier:
NCT01467453
First received: November 3, 2011
Last updated: November 14, 2011
Last verified: November 2011
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The study objective is to investigate the clinical applicability of continuous IOP measurement using TS with radio transmission over 24 hours.
- Trial with medical device
| Condition | Intervention | Phase |
|---|---|---|
|
Glaucoma |
Device: Triggerfish |
Phase 4 |
| Study Type: | Observational |
| Study Design: | Observational Model: Case-Only Time Perspective: Prospective |
Resource links provided by NLM:
Genetics Home Reference related topics:
early-onset glaucoma
MedlinePlus related topics:
Glaucoma
U.S. FDA Resources
Further study details as provided by University of Zurich:
| Estimated Enrollment: | 30 |
| Study Start Date: | November 2011 |
| Estimated Study Completion Date: | December 2012 |
Intervention Details:
-
Device: Triggerfish
The Triggerfish is a contact lens with an embedded sensor to track changes in intraocular pressure during a period of 24 hours.
Other Name: Triggerfish, SENSIMED AG, Route de Chavannes 37, 1007 Lausanne, Switzerland
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Study Population
patients with a diagnosis of glaucoma
Criteria
Inclusion criteria:
- Clinical diagnosis of glaucoma
Exclusion criteria:
- Other opticus neuropathy than glaucoma
- Corneal abnormalities (e.g. scaring)
- Dry eye disease
Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01467453
Locations
| Switzerland | |
| University Hospital Zurich, Ophthalmic Clinic | |
| Zurich, Switzerland | |
Sponsors and Collaborators
University of Zurich
Investigators
| Study Director: | 01 Studienregister MasterAdmins | UniversitaetsSpital Zuerich |
| Principal Investigator: | Christoph Kniestedt, Assistant Prof, MD | University Hospital Zurich, Ophtalmic Clinic |
More Information
No publications provided
| Responsible Party: | University of Zurich |
| ClinicalTrials.gov Identifier: | NCT01467453 History of Changes |
| Other Study ID Numbers: | Triggerfisch-001 |
| Study First Received: | November 3, 2011 |
| Last Updated: | November 14, 2011 |
| Health Authority: | Switzerland: Swissmedic |
Additional relevant MeSH terms:
|
Glaucoma Ocular Hypertension Eye Diseases |
ClinicalTrials.gov processed this record on May 19, 2013